Clinical Trial: Registry of Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia
Study Status: Completed
Recruit Status: RECRUITING
Condition: Relapsed/Refractory Acute Lymphoblastic Leukemia
Study Type: OBSERVATIONAL
Official Title: Observatory for Patients Treated for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia With Oncogenetic Features.
Brief Summary:
In order to improve the outcome of relapsed and/or refractory T-cell precursor acute lymphoblastic leukemia (T-ALL) patients, and to facilitate the use of oncogenetic targeted therapies in these patients, we set up an observational cohort, collecting clinical and biological information's from patients with T-ALL in relapse or refractory, as well as the use or not of a targeted therapy.The analysis of the cohort will allow us to evaluate the impact of this therapeutic strategies on the patients'…
Read more